Phase I study of the novel, oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK): Evaluating the pharmacokinetic effect of a high-fat meal in patients with hormone-refractory prostate cancer (HRPC)
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: D. George, W. Oh, T. Gilligan, E. Masson, C. Souppart, Y. Wang, Y. Ho, D. Lebwohl, D. Laurent, P. Kantoff
Institution: Duke University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2332652021